EFG Magazine

Erin Griffith (@eringriffith) and Erin Woo (@erinkwoo), two of our tech reporters, are covering the trial of Elizabeth Holmes, who dropped out of Stanford University to create the blood testing start-up Theranos at age 19 and built it to a $9 billion valuation and herself into the world’s youngest self-made female billionaire — only to flame out in disgrace after Theranos’s technology was revealed to have problems.

Follow along here or on Twitter as she is tried on 12 counts of wire fraud and conspiracy to commit wire fraud. The trial is generally held Tuesdays, Wednesdays and Fridays.

Erin Woo headshot

Oct. 15, 7:38 p.m. UTC

Erin Woo

Edlin conducted trainings for Walgreens staff and would give tours around Theranos. “In advance of the tour, there were some areas of the labs that were hidden by a partition” to conceal Theranos devices, Edlin testifies.

Erin Woo headshot

Oct. 15, 7:38 p.m. UTC

Erin Woo

With that, we're breaking for the weekend. We'll pick up with Edlin on Tuesday.

Erin Woo headshot

Oct. 15, 7:37 p.m. UTC

Erin Woo

We’re looking at an email chain between Edlin, Daniel Young, Michael Craig and others, preparing for a tech demonstration. They decide to go with the demo app, which “shields protocol failures from the client,” Craig wrote. If an error had taken place, it wouldn’t show on the screen that an error had taken place. It would say running or processing, Edlin said.

Erin Woo headshot

Oct. 15, 7:30 p.m. UTC

Erin Woo

Edlin was aware at the time of Theranos using modified third-party devices to run venous draws but did not know the third-party devices were used for fingerstick draws until 2016.

Erin Woo headshot

Oct. 15, 7:28 p.m. UTC

Erin Woo

Edlin worked on the “front-end customer experience” for the Walgreens partnership, including the store’s branding and marketing as well as software used by patients and technicians. Edlin testifies that he was familiar with the Edison machines (3.0 and 3.5), the MiniLab, and the Edison 4 series (the next-gen version of the Theranos devices). The next-gen versions were never used for clinical patient testing, he testifies.